Analyst Consensus ?
ConsensusHold40 ratings
Bullish2152.5%
Neutral1640.0%
Bearish37.5%
FN2 Earnings Intelligence
Emerson Electric Co. complete analyst coverage
Emerson Electric Co. (EMR) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$151.81Previous close
$86Low
$134.44Average
$185High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Neutral | Upgrade | Jul 17, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 7, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | May 6, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 6, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Feb 9, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 5, 2026 |
| Deutsche Bank | Hold | Buy | Downgrade | Feb 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 4, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Jan 27, 2026 |
| UBS | Buy | Neutral | Upgrade | Jan 5, 2026 |
| Jefferies | Hold | Buy | Downgrade | Dec 10, 2025 |
| B of A Securities | Buy | Buy | Maintain | Jul 2, 2025 |
| Keybanc | Overweight | Overweight | Maintain | Jul 1, 2025 |
| Baird | Neutral | Neutral | Maintain | May 8, 2025 |
| Morgan Stanley | Underweight | Underweight | Maintain | Feb 6, 2025 |
| Loop Capital | Buy | Buy | Maintain | Dec 2, 2024 |
| Mizuho | Buy | Buy | Maintain | May 9, 2024 |
| Berenberg | Buy | Buy | Maintain | Mar 6, 2024 |
| Vertical Research | Buy | Hold | Upgrade | Sep 15, 2023 |
| Argus Research | Buy | Hold | Upgrade | Aug 28, 2023 |
| HSBC | Buy | Hold | Upgrade | Jun 15, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 18, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 21, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 10, 2022 |
| Bernstein | Perform | Market Perform | Maintain | Jan 11, 2022 |
| Goldman Sachs | Buy | Neutral | Upgrade | Jan 19, 2021 |
| Argus | Hold | Buy | Downgrade | Aug 13, 2019 |
| Bank of America | Buy | Buy | Maintain | Oct 4, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 3, 2018 |
| Stifel | Buy | Buy | Maintain | May 3, 2018 |
| JMP Securities | Market Perform | Market Outperform | Downgrade | Feb 1, 2018 |
| Buckingham Research | Underperform | Neutral | Downgrade | Aug 19, 2016 |
| CLSA | Underperform | Sell | Maintain | Aug 3, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Feb 29, 2016 |
| Societe Generale | Hold | Buy | Downgrade | Nov 5, 2015 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Feb 9, 2015 |
| Nomura | Buy | Buy | Maintain | Feb 3, 2015 |
| Canaccord Genuity | Hold | Hold | Maintain | Mar 27, 2013 |
| Ladenburg Thalmann | Hold | Buy | Downgrade | Feb 6, 2013 |
| Macquarie | Neutral | Outperform | Downgrade | Oct 1, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $151.81. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Analyst unavailable | $169 | $139.56 | +11.3% | Jul 20, 2026 |
| KeyBanc | Ken Newman | $170 | $138.88 | +12.0% | Jul 13, 2026 |
| Wolfe Research | Analyst unavailable | $167 | $138.9 | +10.0% | Jul 9, 2026 |
| D.A. Davidson | Chris Dankert | $145 | $146.52 | -4.5% | Jun 15, 2026 |
| Bernstein | Varun Govindaraj | $175 | $142.42 | +15.3% | Jun 9, 2026 |
| RBC Capital | Analyst unavailable | $169 | $145.68 | +11.3% | May 6, 2026 |
| Barclays | Analyst unavailable | $144 | $138.4 | -5.1% | May 6, 2026 |
| BMO Capital | Daniel DiCicco | $150 | $126.31 | -1.2% | Mar 26, 2026 |
| Stephens | Analyst unavailable | $155 | $157.38 | +2.1% | Feb 9, 2026 |
| Evercore ISI | Analyst unavailable | $185 | $153.02 | +21.9% | Feb 5, 2026 |
| KeyBanc | Analyst unavailable | $185 | $157.32 | +21.9% | Feb 5, 2026 |
| Deutsche Bank | Nicole Deblase | $170 | $157.32 | +12.0% | Feb 4, 2026 |
| RBC Capital | Deane Dray | $176 | $155.84 | +15.9% | Feb 4, 2026 |
| Mizuho Securities | Brett Linzey | $173 | $152.1 | +14.0% | Feb 4, 2026 |
| Robert W. Baird | Analyst unavailable | $168 | $157.54 | +10.7% | Feb 4, 2026 |
| Wells Fargo | Joseph O'Dea | $160 | $152.1 | +5.4% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $125 | $144.25 | -17.7% | Jan 9, 2026 |
| Barclays | Analyst unavailable | $145 | $145.62 | -4.5% | Jan 7, 2026 |
| Wells Fargo | Joseph O'Dea | $145 | $145.62 | -4.5% | Jan 7, 2026 |
| UBS | Analyst unavailable | $168 | $135.82 | +10.7% | Jan 4, 2026 |
| Evercore ISI | Analyst unavailable | $170 | $136.64 | +12.0% | Dec 15, 2025 |
| Jefferies | Saree Boroditsky | $145 | $135.28 | -4.5% | Dec 10, 2025 |
| Wells Fargo | Joseph O'Dea | $135 | $116.15 | -11.1% | May 21, 2025 |
| Barclays | Analyst unavailable | $110 | $118.57 | -27.5% | Mar 10, 2025 |
| Wells Fargo | Joseph O'Dea | $140 | $120.68 | -7.8% | Jan 7, 2025 |
| Loop Capital Markets | Chris Dankert | $155 | $132.03 | +2.1% | Dec 2, 2024 |
| Oppenheimer | Christopher Glynn | $150 | $126.86 | -1.2% | Nov 6, 2024 |
| KeyBanc | Ken Newman | $140 | $117.27 | -7.8% | Nov 6, 2024 |
| Robert W. Baird | Michael Halloran | $125 | $117.27 | -17.7% | Nov 6, 2024 |
| Mizuho Securities | Brett Linzey | $140 | $117.27 | -7.8% | Nov 6, 2024 |
| Deutsche Bank | Nicole DeBlase | $140 | $117.67 | -7.8% | Nov 5, 2024 |
| KeyBanc | Ken Newman | $125 | $117.27 | -17.7% | Nov 5, 2024 |
| Morgan Stanley | Christopher Snyder | $105 | $99.97 | -30.8% | Sep 6, 2024 |
| Mizuho Securities | Brett Linzey | $130 | $99.54 | -14.4% | Aug 8, 2024 |
| RBC Capital | Deane Dray | $139 | $99.54 | -8.4% | Aug 8, 2024 |
| Argus Research | John Eade | $130 | $114.82 | -14.4% | May 14, 2024 |
| Loop Capital Markets | Chris Dankert | $135 | $115.88 | -11.1% | May 10, 2024 |
| Wells Fargo | Joseph O'Dea | $133 | $112.65 | -12.4% | May 9, 2024 |
| Mizuho Securities | Brett Linzey | $135 | $112.65 | -11.1% | May 9, 2024 |
| RBC Capital | Deane Dray | $140 | $112.65 | -7.8% | May 9, 2024 |
| Robert W. Baird | Michael Halloran | $116 | $112.65 | -23.6% | May 9, 2024 |
| Deutsche Bank | Nicole DeBlase | $138 | $112.65 | -9.1% | May 8, 2024 |
| Barclays | Julian Mitchell | $105 | $113.54 | -30.8% | Apr 2, 2024 |
| Mizuho Securities | Brett Linzey | $118 | $94.68 | -22.3% | Jan 4, 2024 |
| Morgan Stanley | Analyst unavailable | $93 | $89.86 | -38.7% | Feb 7, 2023 |
| UBS | Analyst unavailable | $100 | $96.11 | -34.1% | Jan 4, 2023 |
| Citigroup | Analyst unavailable | $109 | $94.19 | -28.2% | Dec 9, 2022 |
| Wells Fargo | Analyst unavailable | $95 | $93.75 | -37.4% | Nov 30, 2022 |
| RBC Capital | Analyst unavailable | $110 | $93.62 | -27.5% | Nov 30, 2022 |
| Oppenheimer | Analyst unavailable | $115 | $95.98 | -24.2% | Nov 16, 2022 |
| Argus Research | Analyst unavailable | $98 | $89.95 | -35.4% | Aug 16, 2022 |
| RBC Capital | Deane Dray | $102 | $87.5 | -32.8% | Aug 10, 2022 |
| Deutsche Bank | Analyst unavailable | $99 | $87.46 | -34.8% | Aug 10, 2022 |
| Credit Suisse | Analyst unavailable | $106 | $88.06 | -30.2% | Aug 10, 2022 |
| Morgan Stanley | Analyst unavailable | $97 | $87.92 | -36.1% | Aug 10, 2022 |
| Mizuho Securities | Analyst unavailable | $86 | $87.92 | -43.4% | Aug 10, 2022 |
| Mizuho Securities | Analyst unavailable | $85 | $79.94 | -44.0% | Jul 18, 2022 |
| Deutsche Bank | Analyst unavailable | $97 | $78.71 | -36.1% | Jul 13, 2022 |
| Wells Fargo | Analyst unavailable | $89 | $79.05 | -41.4% | Jul 13, 2022 |
| Barclays | Analyst unavailable | $80 | $80.87 | -47.3% | Jul 8, 2022 |
| Wells Fargo | Analyst unavailable | $87 | $81.52 | -42.7% | Jun 29, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $95 | $90.25 | -37.4% | Jun 7, 2022 |
| Barclays | Julian Mitchell | $87 | $88.4 | -42.7% | May 31, 2022 |
| Wells Fargo | Analyst unavailable | $96 | $88.01 | -36.8% | May 9, 2022 |
| Wells Fargo | Joseph O’Dea | $100 | $90.38 | -34.1% | May 2, 2022 |
| Wolfe Research | Nigel Coe | $115 | $98.42 | -24.2% | Apr 3, 2022 |
| Oppenheimer | Christopher Glynn | $110 | $93.76 | -27.5% | Mar 16, 2022 |
| Citigroup | Andrew Kaplowitz | $123 | $96.59 | -19.0% | Feb 3, 2022 |
| Bernstein | Brendan Luecke | $100 | $94.8 | -34.1% | Jan 10, 2022 |
| Barclays | Julian Mitchell | $99 | $95.33 | -34.8% | Jan 4, 2022 |
| UBS | Markus Mittermaier | $116 | $94.08 | -23.6% | Nov 18, 2021 |
| Loop Capital Markets | Chris Dankert | $124 | $93.82 | -18.3% | Nov 17, 2021 |
| Berenberg Bank | Phil Buller | $100 | $96.32 | -34.1% | Oct 7, 2021 |
| Stephens | Tommy Moll | $120 | $96.32 | -21.0% | Oct 7, 2021 |
| Cowen & Co. | Gautam Khanna | $115 | $103.02 | -24.2% | Aug 12, 2021 |
| Bank of America Securities | Andrew Obin | $120 | $99.52 | -21.0% | Aug 5, 2021 |
| J.P. Morgan | Stephen Tusa | $100 | $93.24 | -34.1% | Jun 29, 2021 |
Track every rating change on EMR the moment it posts. Free to start.
Start free